Pharma-Bio Serv, Inc. (PBSV) stock: key figures, P/E, revenue and dividend
Industrials · United States · ISIN US71711N1000
Pharma-Bio Serv, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 9.00 m USD |
| Gross profit | 2.91 m USD |
| Operating income | -637,662.00 USD |
| EBIT | -131,786.00 USD |
| Net income | -100,463.00 USD |
| Diluted EPS – continuing operations | -0.00 USD |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Pharma-Bio Serv, Inc.
Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
More stocks
- Granite Point Mortgage Trust Inc. (GPMT)
- Smartbird, Inc. (BIRD)
- CARVER BANCORP INC (CARV)
- TAITRON COMPONENTS INC (TAIT)
- Lifeward Ltd. (LFWD)
- GLEN BURNIE BANCORP (GLBZ)
- Cellectar Biosciences, Inc. (CLRB)
- Clean Energy Technologies, Inc. (CETY)
- Anebulo Pharmaceuticals, Inc. (ANEB)
- URBAN ONE, INC. (UONEK)
- VerifyMe, Inc. (VRME)
- UNIVERSAL SAFETY PRODUCTS, INC. (UUU)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.